Skip To Main Content
  • Article
  • Source: Campus Sanofi

RCT Evidence on Time-In-Range in Type 1 Diabetes

RCT Evidence on Time-In-Range in Type 1 Diabetes

Length: 13:04

Dr Amar Puttanna presents the findings from the InRange study, that compares second generation basal insulins in adults with T1DM, using Time-In-Range as the primary endpoint.

Recommended Videos

Our Products

MAT-IE-2300491 (v1.0) Date of Preparation: June 2024